• 論文・教科書等

Designed by Freepik

<2018年>

Clarithromycin mitigates radiation pneumonitis in patients with lung cancer treated with stereotactic body radiotherapy
Takeda A, Tsurugai Y, Sanuki N, Enomoto T, Shinkai M, Mizuno T, Aoki Y, Oku Y, Akiba T, Hara Y,Kunieda E.
J Thorac dis 2018 ePub ahead of print
肝臓に対するRapidArc-70% isodose処方法を用いた体幹部定位放射線治療
武田篤也,鶴貝雄一郎,奥洋平
INNERVISION (33,6) 2018 pp.76-77 Varian RT REPORT「ここまでできるがん放射線治療シリーズ」
肺がんに対するRapidArc-60% isodose処方法を用いた体幹部定位放射線治療
武田篤也,鶴貝雄一郎,奥洋平
INNERVISION (33,5) 2018 pp.98-99 Varian RT REPORT「ここまでできるがん放射線治療シリーズ」
がん患者さんの知っ得はなし(がんプラス(QLife)の連載コラム)
武田篤也

<2017年>

RapidArcを用いた全脳全脊髄に対する放射線治療
奥洋平
INNERVISION (33,1) 2018 pp.70-71 Varian RT REPORT「ここまでできるがん放射線治療シリーズ」
Stereotactic body radiotherapy for operable early-stage non-small cell lung cancer
Eriguchi T, Takeda A, Sanuki N, Tsurugai Y, Aoki Y, Oku Y, Hara Y, Akiba T, Shigematsu N.
lung cancer 2017 Epub
Stereotactic body radiotherapy for lung cancer patients with idiopathic interstitial pneumonias
Tsurugai Y, Takeda A, Sanuki N, Enomoto T, Kaneko T, Hara Y, Mizuno T, Saeki N, Aoki Y, Oku Y, Akiba T, Kunieda E.
Radiother Oncol. 2017; 125(2): :310-316.

<2016年>

Stereotactic body radiotherapy for chronic obstructive pulmonary disease patients undergoing or eligible for long-term domiciliary oxygen therapy
Hara Y, Takeda A, Eriguchi T, Sanuki N, Aoki Y, Nishimura S, Enomoto T, Shinkai M, Kawana A, Kaneko T.
J Radiat Res. 2016 Jan;57(1):62-7
放射線有害反応と対策8 放射線治療における注意事項 ―ペースメーカーと植え込み型除細動器―
佐貫直子,鶴貝雄一郎,武田篤也
乳癌の臨床 2016; 31(1), p37-42
Relationship between the consolidation to maximum tumor diameter ratio and outcomes following stereotactic body radiotherapy for stage I non-small-cell lung cancer.
Tsurugai Y, Kozuka T, Ishizuka N, Oguchi M.
Lung Cancer. 2016 Feb;92:47-52
汎用放射線治療装置における呼吸性移動対策
奥洋平
臨床放射線2016年2月号(61巻 02号)p303-312
Stereotactic body radiotherapy (SBRT) for T3 and T4N0M0 non-small cell lung cancer
Eriguchi T, Takeda A, Sanuki N, Nishimura S, Takagawa Y, Enomoto T, Saeki N, Yashiro K, Mizuno T, Aoki Y, Oku Y, Yokosuka T, Shigematsu N
J Radiat Res. Accepted
Stereotactic Body Radiotherapy for Patients with Oligometastases from Colorectal Cancer: Risk-adapted Dose Prescription with a Maximum Dose of 83-100 Gy in 5 Fractions
Takeda A, Sanuki N, Tsurugai Y,Oku Y, Aoki Y
J Radiat Res. Accepted
Phase II study of stereotactic body radiotherapy and optional trans-arterial chemoembolization for solitary hepatocellular carcinoma not amenable to resection and radiofrequency ablation
Takeda A, Sanuki N, Tsurugai Y, Iwabuchi S, Matsunaga K, Ebinuma H, Imajo K, Aoki Y, Saito H, Kunieda E
Cancer Accepted
【がん放射線療法Update 2016】 疾患別治療成績 ここまで治るようになった!機能温存と生存率向上 肝細胞癌に対する体幹部定位放射線治療(SBRT) 肝細胞癌に対する根治治療のひとつの選択肢として
武田篤也,佐貫直子,鶴貝雄一郎
医学のあゆみ257巻1号 Page85-92
肺癌に対する体幹部定位放射線治療の適応の現状および手術との比較 手術とSBRTの成績に明確な生存率の差は証明されていない
大西洋,武田篤也
日本医事新報4786号 Page58 日本医事新報のページへ
リニアックによる定位放射線治療の実際
武田篤也,奥洋平,佐貫直子,鶴貝雄一郎
インナービジョン11月号(特集・放射線治療最前線 新しい高精度放射線治療の現状と展望)Page18-22
HCCに対する体幹部定位放射線治療(SBRT)
武田篤也,佐貫直子,鶴貝雄一郎
肝胆膵11月号(特集・新規技術が創り出す肝疾患診療のスペクタクル)Page787-796

<2015年>

放射線治療の最近の話題 放射線治療におけるPET/ CTの意義 早期肺癌に対する体幹部定位放射線治療を中心に
武田篤也,佐貫直子,横須賀典子,小澤幸彦
Radioisotopes 2015; 64(2): 145-167
Dose-Escalated Stereotactic Body Radiotherapy (SBRT) as a Salvage Treatment for Two Cases with Relapsed Peripheral Lung Cancer After Initial SBRT.
Nishimura S, Takeda A, Sanuki N, Yoshida S, Shigematsu N.
J Thorac Oncol. 2015;10(8) :e69-71.
Influence of liver toxicities on prognosis after stereotactic body radiation therapy for hepatocellular carcinoma.
Sanuki N, Takeda A, Oku Y, Eriguchi T, Nishimura S, Aoki Y, Kunieda E.
Hepatol Res. 2015; 45(5): 540-7.
肝癌に対する放射線治療(座談会)
奥坂 拓志, 井垣 浩, 武田 篤也, 藤 浩, 安田 茂雄
The Liver Cancer Journal 2015; 7(3): 169-177
肝癌に対する定位放射線治療の適応と注意点(Q&A)
武田 篤也, 萬 篤憲
日本医事新報 2015; 4772: 55-56 日本医事新報のページへ
放射線治療の最近の話題 放射線治療におけるPET/ CTの意義 早期肺癌に対する体幹部定位放射線治療を中心に
武田 篤也, 佐貫 直子, 横須賀 典子, 小澤 幸彦
Radioisotopes 2015; 64(2): 145-167

<2014年>

2 間質性肺炎合併肺がんの放射線治療
佐貫直子 榎本達治 武田篤也
「ガイドラインには載っていない 肺がんPractical Treatment IIこんなとき治療をどうするか? 1.間質性肺炎合併肺がん」p.12-16,メジカルビュー社2014/2/10
Threshold Doses for Focal Liver Reaction After Stereotactic Ablative Body Radiation Therapy for Small Hepatocellular Carcinoma Depend on Liver Function: Evaluation on Magnetic Resonance Imaging With Gd-EOB-DTPA
Sanuki N, Takeda A, Oku Y, Eriguchi T, Nishimura S, Aoki S, Mizuno T, Iwabuchi S, and Kunieda E
Int J Radiation Oncol Biol Phys, Vol. 88, No. 2, pp. 306 e 311, 2014
Feasibility study of stereotactic body radiotherapy for peripheral lung tumors with a maximum dose of 100 Gy in five fractions and a heterogeneous dose distribution in the planning target volume
Takeda A, Oku Y, Sanuki N, Eriguchi T, Aoki T, Enomoto T, Kaneko T, Nishimura S, Kunieda E
J Radiat Res. 2014; 55(5): 988-95
Q58 肝癌に対する体幹部定位放射線治療の適応と治療成績について教えてください。
武田篤也 佐貫直子 江里口貴久
肝癌診療Q&A p233-236 中外医学社 2013/10/15
Influence of liver toxicities on prognosis after stereotactic body radiation therapy for hepatocellular carcinoma
SanukiN, Takeda A, Oku Y, Eriguchi T, Nishimura S, Aoki Y, Kunieda E
Hepatol Res 2014 epub ahead of print
Role of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma
Sanuki N, Takeda A, Kunieda E
World Journal of Gastroenterology 2014 ; 20(12): 3100-3111
Role of stereotactic body radiotherapy for oligometastasis from colorectal cancer
Takeda A, Sanuki N, Kunieda E
World Journal of Gastroenterology 2014; 20(15):4220-9.
第2部トピックス 3.肝癌の診断・治療 2.肝癌に対する多様化する放射線治療
武田篤也,櫻井英幸,佐貫直子,奥村敏之,西村修一
肝疾患 review 2014-2015 監修:小俣政男,編集:椎名秀一郎,坂本直哉,丸澤宏之,出版社:日本メディカルセンター 2014/6/2
The Japanese Breast Cancer Society clinical practice guideline for radiotherapy of breast cancer
Sekiguchi K, Ogawa Y, Sanuki N, Arahira S, OgoE, Yoshimura M, Yamauchi C, Oguchi M, Ohsumi S, Mukai H
Breast Cancer. 2014 Jul 15. [Epub ahead of print]
Toxicities of organs at risk in the mediastinal and hilar regions following stereotactic body radiotherapy for centrally located lung tumors.
Nishimura S, Takeda A, Sanuki N, Ishikura S, Oku Y, Aoki Y, Kunieda E, Shigematsu N.
J Thorac Oncol. 2014 Sep;9(9):1370-6.
Stereotactic ablative radiotherapy for small hepatocellulacr carcinoima: outcomes in 185 patients
Sanuki N, Takeda A, Oku Y, Mizuno T, Aoki Y, Eriguchi T, Iwabuchi S, Kunieda E
Acta Oncol 2014; 53(3): 399-404
Stereotactic Ablative Body Radiotherapy with Dynamic Conformal Multiple Arc Therapy for Liver Tumors: Optimal Isodose Line Fitting to the Planning Target Volume.
Oku Y, Takeda A, Sanuki N, Sudo Y, Oooka Y, Aoki Y, Shimouchi Y , Nishina R, Nomura K, Eriguchi T, Kunieda E
Pract Radiat Oncol. 2014; 4(1): e7-e13
【放射線治療最前線2014】肺癌治療における最近のトピック
武田篤也,佐貫直子,下内欣亮
映像情報メディカル 2014; 46(13): 1108-1116
【最新肝臓学-基礎と臨床の最新研究動向-】肝癌の治療 放射線治療 肝癌に対する体幹部定位放射線治療
武田篤也,佐貫直子,高川佳明,西村修一,江里口貴久
日本臨床 2014; 73(s1): 714-719
直著癌術後の異時性肝・傍大動脈リンパ節・多発肺転移切除さらに両側肺転移の定位放射線治療後の局所再発に対してサルベージ手術を行い長期生存が得られている1例
横須賀哲哉,中島康,小林利子,武田篤也,安野正道
癌と化学療法 2014; 41(12): 2053-55

<2013年>

Reassessment of differences in pulmonary function before vs. more than 1 year after stereotactic body radiotherapy (SBRT) for lung tumors classified by GOLD stage.
Takeda A, Kunieda E, Sanuki N, Aoki Y, Oku Y, Handa H.
Chest 2013; 143(1): 130-7
Acceptable Toxicity After Stereotactic Body Radiation Therapy for Liver Tumors Adjacent to the Central Biliary System International Journal of Radiation Oncology Biology Physics, 2012 (In Press Corrected Proof)
Takahisa Eriguchi, Atsuya Takeda, Naoko Sanuki, Yohei Oku, Yousuke Aoki, Naoyuki Shigematsu, Etsuo Kunieda
Int J Radiat Oncol Biol Phys. 2013; 85(4): 1006-10
Outcomes of Clinically Node-Negative Breast Cancer Without Axillary Dissection: Can Preserved Axilla Be Safely Treated With Radiation After a Positive Sentinel Node Biopsy?
Naoko Sanuki, Atsuya Takeda, Atsushi Amemiya, Toru Ofuchi, Masashi Ono, Haruki Ogata, Ryo Yamagami, Jun Hatayama, Takahisa Eriguchi, Etsuo Kunieda
Clinical Breast Cancer, 2013 Feb;13(1):69-76
Stereotactic ablative body radiotherapy (SABR) for octogenarians with non-small cell cancer
Takeda A, Sanuki N, Eriguchi T, Kaneko T, Morita S, Handa H, Aoki Y, Oku Y, Kunieda E
Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):257-63
肝細胞癌に対するSBRTのピットフォール
佐貫直子,武田篤也,奥洋平,江里口貴久,国枝悦夫
臨床放射線 58:682-690, 2013
PMRT 用語解説
佐貫直子,武田篤也
Cancer Board乳癌 Vol.6:No.1, p.96-97, 2013
Multi-institutional comparison of treatment planning using stereotactic ablative body radiotherapy for hepatocellular carcinoma – benchmark for a prospective multi-institutional study
Eriguchi T, Takeda A, Oku Y, Ishikura S, Kimura T, Ozawa S, Nakashima T, Matsuo Y, Nakamura M, Matsumoto Y, Yamazaki S, Sanuki N, Ito Y
Radiat Oncol. 2013; 8: 113
Stereotactic ablative body radiation therapy with dynamic conformal multiple arc therapy for liver tumors: Optimal isodose line fitting to the planning target volume
Oku Y, Takeda A, Sanuki N, Sudo Y, Oooka Y, Aoki Y, Shimouchi Y, Nishina R, Nomura K, Eriguchi T, Kunieda E
Practical Radiation Oncol. 2003: 2014 Jan; 4(1): e7-13
Evaluation of microscopic tumor extension in early-stage cervical cancer: quantifying subclinical uncertainties by pathological and magnetic resonance imaging findings
Sanuki N, Urabe S, Matsumoto H, Ono A, Komatsu E, Kamei N, Maeda T
J Radiat Res 2013; 54(4):719-26
Stereotactic body radiotherapy for small hepatocellular carcinoma: A retrospective outcome analysis in 185 patients
Sanuki N, Takeda A, Oku Y, Mizuno T, Aoki Y, Eriguchi T, Iwabuchi S, Kunieda E
Acta Oncol 2013: [Epub ahead of print]
Tumor Response on Computed Tomography (CT) Following Hypofractionated Stereotactic Body Radiotherapy (SBRT) for Small Hypervascular Hepatocellular Carcinoma (HCC) with Cirrhosis
Sanuki N, Takeda A, Mizuno T, Oku Y, Eriguchi T, Iwabuchi S, Kunieda E
AJR 2013 Dec;201(6):W812-20
The maximum standardized uptake value (SUVmax) on FDG-PET is a strong predictor of overall and disease-free survival for non-small-cell lung cancer patients following stereotactic body radiotherapy (SBRT)
Takeda A, Sanuki N, Fujii H, Yokosuka N, Nishimura S, Aoki Y, Oku Y, Ozawa Y, Kunieda E
J Thorac Oncol 2013; 2014 Jan;9(1):65-73
Stereotactic ablative body radiotherapy for previously untreated solitary hepatocellular carcinoma
Takeda A, Sanuki N, Eriguchi T, Kobayashi T, Iwabutchi S, Matsunaga K, Mizuno T, Yashiro K, Nisimura S, Kunieda E
J Gastroenterol Hepatol 2013: 2014 Feb;29(2):372-9
Salvage Stereotactic Ablative Irradiation for Isolated Postsurgical Local Recurrence of Lung Cancer
Takeda A, Sanuki N, Eriguchi T, Enomoto T, Yokosuka T, Kaneko T, Handa H, Aoki Y, Oku Y, Kunieda E
Ann Thorac Surg 2013: 2013 Nov;96(5):1776-82
Axillary Irradiation with High Tangent Fields for Clinically Node-negative Breast Cancer: Can 3-Dimensional Conformal Radiotherapy with a Field-in-field Technique Better Control the Axilla?
Sanuki N, Takeda A, Amemiya A, Ofuchi T, Ono M, Ogata H, Yamagami R, Hatayama J, Eriguchi T, Kunieda E
Breast Care (Basel). 2013 Oct;8(5):362-7.
A case of recurrent non-small cell lung cancer successfully treated with multiple modality therapies including S-1 monotherapy as fifth-line chemotherapy hospital.
Yokosuka T, Kobayashi T, Enomoto T, Takeda A
Gan To Kagaku Ryoho 2013; 40(9): 1201-3
術後断端再発例への救済的体幹部定位放射線治療
武田篤也,江里口貴久,佐貫直子
日本臨床 2013; 71 (supple 6): 662-666
Threshold Doses for Focal Liver Reaction Following Stereotactic Ablative Body Radiotherapy for Small Hepatocellular Carcinoma Depend on Liver Function: Evaluation on Magnetic Resonance Imaging with Gd-EOB-DTPA
Sanuki N, Takeda A, Oku Y, Mizuno T, Aoki Y, Eriguchi T, Nishimura S, Iwabuchi S, Kunieda E
Int J Radiat Oncol Biol Phys. 2014; 88(2):306-11
Subclinical interstitial lung disease: Is it a risk factor for fatal radiation pneumonitis following stereotactic body radiotherapy?
Takeda A, Sanuki N, Enomoto T, Kunieda E.
Lung Cancer. 2014; 83(1):112
Locally advanced granulocyte colony-stimulating factor-producing non-small cell lung cancer successfully treated with concurrent chemoradiotherapy.
Yokosuka T, Enomoto T, Takeda A, Kobayashi T.
Gan To Kagaku Ryoho. 2013 Nov;40(12):2330-2.

<2012年>

Comparison of clinical, tumour-related and dosimetric factors in grade 0-1, grade 2 and grade 3 radiation pneumonitis after stereotactic body radiotherapy for lung tumours.
Takeda A, Ohashi T, Kunieda E, Sanuki N, Enomoto T, Takeda T, Oku Y, Shigematsu N.
Br J Radiol. 2012;85(1013):636-42.
Dose volume histogram analysis of focal liver reaction in follow-up multiphasic CT following stereotactic body radiotherapy for small hepatocellular carcinoma.
Takeda A, Oku Y, Sanuki N, Kunieda E, Koike N, Aoki Y, Ohashi T, Iwabuchi S, Takatsuka K, Takeda T, Sugawara A.
Radiother Oncol. 2012;104(3):374-8
Stereotactic body radiotherapy (SBRT) for solitary pulmonary nodules clinically diagnosed as lung cancer with no pathological confirmation: Comparison with non-small-cell lung cancer.
Takeda A, Kunieda E, Sanuki N, Aoki Y, Oku Y, Handa H.
Lung Cancer. 2012;77(1):77-82
Acute exacerbation of usual interstitial pneumonia after resection of lung cancer.
Sugiura H, Takeda A, Hoshi T, Kawabata Y, Sayama K, Jinzaki M, Kuribayashi S.
Ann Thorac Surg. 2012 Mar;93(3):937-43.
Analysis of suitable prescribed isodose line fitting to planning target volume in stereotactic body radiotherapy using dynamic conformal multiple arc therapy
Oku Y, Takeda A, Kunieda E, Sudo Y, Oooka Y, Aoki Y, Shimouchi Y, Nishina R, Nomura K, Sugiura M, Ohashi T.
Practical Radiation Oncol 2011;2(1):46-53
Severe COPD is correlated with mild radiation pneumonitis following stereotactic body radiotherapy.
Takeda A, Kunieda E, Ohashi T, Aoki Y, Oku Y, Enomoto T, Nomura K, Sugiura M.
Chest. 2012 ;141(4):858-66.
Multiple myeloma relapse in the irradiated liver: involvement of hepatocyte growth factor akin to that after hepatocyte transplantation.
Uetake A, Takeda A, Shigematsu N, Ikeda E, Kametaka M, Kunieda E, Ohashi T.
Journal of Radiotherapy in Practice 2012;11:271-3
Evaluation for local failure by CT and 18F-FDG PET/CT at one year after stereotactic body radiotherapy (SBRT) for localized non-small-cell lung cancer
Takeda A, Kunieda E, Fujii H, Yokosuka N, Aoki Y, Oooka Y, Oku Y, Ohashi T, Sanuki N, Mizuno T, Ozawa Y.
lung cancer 2012; 79(3):248-53
肝細胞癌に対する体幹部定位放射線治療 体幹部定位放射線治療の効果と位置づけ
武田篤也,佐貫直子,江里口貴久
Liver Cancer Journal. 2012 ; 4(4): 43-48

<2011年>

Radiotherapy quality assurance review for a multi-center randomized trial of locally advanced esophageal cancer: the Japan Clinical Oncology Group (JCOG) trial 0303.
Sanuki N, Ishikura S, Shinoda M, Ito Y, Hayakawa K, Ando N.
Int J Clin Oncol. 2011 Jun 14.
The maximum standardized uptake value (SUVmax) on FDG-PET is a strong predictor of local recurrence for localized non-small-cell lung cancer after stereotactic body radiotherapy (SBRT).
Takeda A, Yokosuka N, Ohashi T, Kunieda E, Fujii H, Aoki Y, Sanuki N, Koike N, Ozawa Y.
Radiother Oncol. 2011 Nov;101(2):291-7.
Stereotactic body radiotherapy (SBRT) for oligometastatic lung tumors from colorectal cancer and other primary cancers in comparison with primary lung cancer.
Takeda A, Kunieda E, Ohashi T, Aoki Y, Koike N, Takeda T.
Radiother Oncol. 2011 Nov;101(2):255-9.
Stereotactic Body Radiotherapy (SBRT) for Operable Stage I Non-Small-Cell Lung Cancer: Can SBRT Be Comparable to Surgery?
Onishi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, Gomi K, Karasawa K, Hayakawa K, Niibe Y, Takai Y, Kimura T, Takeda A, Ouchi A, Hareyama M, Kokubo M, Kozuka T, Arimoto T, Hara R, Itami J, Araki T.
Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1352-8.

<2010年>

Early graphical appearance of radiation pneumonitis correlates with the severity of radiation pneumonitis after stereotactic body radiotherapy (SBRT) in patients with lung tumors.
Takeda A, Ohashi T, Kunieda E, Enomoto T, Sanuki N, Takeda T, Shigematsu N.
Int J Radiat Oncol Biol Phys. 2010 Jul 1;77(3):685-90.
CT evaluations of focal liver reactions following stereotactic body radiotherapy for small hepatocellular carcinoma with cirrhosis: relationship between imaging appearance and baseline liver function.
Sanuki-Fujimoto N, Takeda A, Ohashi T, Kunieda E, Iwabuchi S, Takatsuka K, Koike N, Shigematsu N.
Br J Radiol. 2010 Dec;83(996):1063-71.
【教科書等】癌・放射線療法2010別冊(篠原出版新社,2010/11/25) 第5章消化器腫瘍 5/肝(体幹部定位照射): 68-69
武田篤也
【教科書等】癌・放射線療法2010(篠原出版新社,2010/11/01) 第6章放射線治療技術と方法 6-8/体幹部定位放射線治療:483-97
武田篤也

<2009年>

Discrepancy between the intended isocenter and that from orthogonal linacgrams in the treatment of CT-guided stereotactic body radiotherapy(SBRT).
Oooka Y, Takeda A, Sudo Y, Iwashita H, Aoki Y, Katayose T, Sasajima N, Sanuki N, Oohashi T, Kunieda E, Nagaoka T.
Nihon Hoshasen Gijutsu Gakkai Zasshi. 2009 Jan 20;65(1):41-9. Japanese.
Dose distribution analysis in stereotactic body radiotherapy using dynamic conformal multiple arc therapy
Takeda A, Kunieda E, Sanuki N, Ohashi T, Oku Y, Sudo Y, Iwashita H, Ooka Y, Aoki Y, Shigematsu N, Kubo A.
Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):363-9.
Dose distribution analysis of axillary lymph nodes for three-dimensional conformal radiotherapy with a field-in-field technique for breast cancer.
Ohashi T, Takeda A, Shigematsu N, Fukada J, Sanuki N, Amemiya A, Kubo A.
Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):80-7.
Extrapulmonary soft-tissue fibrosis resulting from hypofractionated stereotactic body radiotherapy for pulmonary nodular lesions.
Kawase T, Takeda A, Kunieda E, Kokubo M, Kamikubo Y, Ishibashi R, Nagaoka T, Shigematsu N, Kubo A.
Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):349-54.
Radiotherapy quality assurance review in a multi-center randomized trial of limited-disease small cell lung cancer: the Japan Clinical Oncology Group (JCOG) trial 0202.
Sanuki-Fujimoto N, Ishikura S, Hayakawa K, Kubota K, Nishiwaki Y, Tamura T.
Radiat Oncol. 2009 Jun 2;4:16.
Stereotactic radiosurgery with an upper partial denture
Tayama S, Kunieda E, Oku Y, Takeda A, Takeda T.
Keio J Med. 2009 Jun;58(2):120-3.
Stereotactic body radiotherapy for primary lung cancer at a dose of 50 Gy total in five fractions to the periphery of the planning target volume calculated using a superposition algorithm.
Takeda A, Sanuki N, Kunieda E, Ohashi T, Oku Y, Takeda T, Shigematsu N, Kubo A.
Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):442-8.
The reproducibility of a HeadFix relocatable fixation system: analysis using the stereotactic coordinates of bilateral incus and the top of the crista galli obtained from a serial CT scan.
Kunieda E, Oku Y, Fukada J, Kawaguchi O, Shiba H, Takeda A, Kubo A.
Phys Med Biol. 2009 May 21;54(10):N197-204.
Relation between elective nodal failure and irradiated volume in non-small-cell lung cancer (NSCLC) treated with radiotherapy using conventional fields and doses.
Sanuki-Fujimoto N, Sumi M, Ito Y, Imai A, Kagami Y, Sekine I, Kunitoh H, Ohe Y, Tamura T, Ikeda H.
Radiother Oncol. 2009 Jun;91(3):433-7.
Clinical Outcomes of Stereotactic Body Radiotherapy for Small Lung Lesions Clinically Diagnosed as Primary Lung Cancer on Radiologic Examination.
Inoue T, Shimizu S, Onimaru R, Takeda A, Onishi H, Nagata Y, Kimura T, Karasawa K, Arimoto T, Hareyama M, Kikuchi E, Shirato H.
Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):683-7.
Weekly Low-Dose Docetaxel-Based Chemoradiotherapy for Locally Advanced Oropharyngeal or Hypopharyngeal Carcinoma: A Retrospective, Single-Institution Study.
Fukada J, Shigematsu N, Takeda A, Ohashi T, Tomita T, Shiotani A, Kunieda E, Kawaguchi O, Fujii M, Kubo A.
Int J Radiat Oncol Biol Phys. 2009;76(2):417-424
ラジオ波焼灼療法後に同区域多発再発を来した肝細胞癌に対し体幹部定位放射線治療が奏功した1例
今城健人,厚川和裕,武田篤也,坂口隆,斯波忠彦,野中敬,岡田和久,千葉秀幸,碓井真吾,高橋久雄,杜文林
Acta hepatologica japonica. 2009; 50: 90-95
体幹部定位放射線治療における骨構造を基準としたアイソセンタ決定の不確かさについて
大岡義一, 武田篤也, 須藤泰信, 岩下秀夫, 青木陽介, 片寄哲朗, 笹嶋範明, 佐貫直子, 大橋俊夫, 国枝悦夫, 長岡智明
日本放射線技術学会誌. 2009; 65: 41-49

<2008年>

Hypofractionated stereotactic radiotherapy with and without transarterial chemoembolization for small hepatocellular carcinoma not eligible for other ablation therapies: Preliminary results for efficacy and toxicity.
Takeda A, Takahashi M, Kunieda E, Takeda T, Sanuki N, Koike Y, Atsukawa K, Ohashi T, Saito H, Shigematsu N, Kubo A.
Hepatol Res. 2008 Jan;38(1):60-9
Pattern of tumor recurrence in initially nonmetastatic breast cancer patients: distribution and frequency of metastases at unusual sites.
Sanuki-Fujimoto N, Takeda A, Amemiya A, Ofuchi T, Ono M, Yamagami R, Hatayama J, Kunieda E, Shigematsu N.
Cancer. 2008 Aug 15;113(4):677-82.
Acute exacerbation of subclinical idiopathic pulmonary fi brosis triggered by hypofractionated stereotactic body radiotherapy in a patient with primary lung cancer and slightly focal honeycombing
Takeda A, Enomoto T, Sanuki N, Nakajima T, Takeda T, Sayama K, Kunieda E.
Radiat Med. 2008 Oct;26(8):504-7.
Gadolinium-Enhanced Three-Dimensional Magnetization-Prepared Rapid Gradient-Echo (3D MP-RAGE) Imaging is Superior to Spin-Echo Imaging in Delineating Brain Metastases.
Takeda T, Takeda A, Nagaoka T, Kunieda E, Takemasa K, Watanabe M, Hatou T, Oguro S, Katayama M.
Acta Radiol. 2008; 49:1167-73

<2007年以前>

Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study.
Onishi H, Shirato H, Nagata Y, Hiraoka M, Fujino M, Gomi K, Niibe Y, Karasawa K, Hayakawa K, Takai Y, Kimura T, Takeda A, Ouchi A, Hareyama M, Kokubo M, Hara R, Itami J, Yamada K, Araki T.
J Thorac Oncol. 2007 Jul;2(7 Suppl 3):S94-100.
Experimental stereotactic irradiation of normal rabbit lung: computed tomographic analysis of radiation injury and the histopathological features.
Kawase T, Kunieda E, Deloar HM, Seki S, Sugawara A, Tsunoo T, Ogawa EN, Ishizaka A, Kameyama K, Takeda A, Kubo A.
Radiat Med. 2007 Nov;25(9):453-61
Differences in the definition of internal target volumes using slow CT alone or in combination with thin-slice CT under breath-holding conditions during the planning of stereotactic radiotherapy for lung cancer.
Seki S, Kunieda E, Takeda A, Nagaoka T, Deloar HM, Kawase T, Fukada J, Kawaguchi O, Uematsu M, Kubo A.
Radiother Oncol. 2007 Dec;85(3):443-9.
肝細胞癌に対する体幹部定位放射線治療の役割
武田篤也,佐貫直子,岩渕省吾,高塚健太郎,中崎晴弘
胆と膵 2007; 28: 727-733
Radiation therapy after breast-conserving surgery.
Shigematsu N, Takeda A, Sanuki N, Fukada J, Uno T, Ito H, Kawaguchi O, Kunieda E, Kubo A.
Radiat Med. 2006 Jun;24(5):388-404. Review.
Rotational and translational reproducibility of newly developed Leksell frame-based relocatable fixation system.
Kunieda E, Deloar HM, Kitamura M, Kawaguchi O, Shiba H, Takeda A, Kawase T, Seki S, Shigematsu N, Kubo A.
Radiat Med. 2006 Aug;24(7):503-10.
Evaluation of acute intestinal toxicity in relation to the volume of irradiated small bowel in patients treated with concurrent weekly gemcitabine and radiotherapy for locally advanced pancreatic cancer.
to Y, Okusaka T, Kagami Y, Ueno H, Ikeda M, Sumi M, Imai A, Fujimoto N, Ikeda H.
Anticancer Res. 2006 Sep-Oct;26(5B):3755-9.
治療計画装置を用いた乳癌術後照射法について(2)
武田篤也,茂松直之
臨床放射線 2006; 51(1): 196-200
【体幹部定位放射線治療】Ⅰ期非小細胞肺癌に対する定位放射線治療 日本多施設共同研究グループの14施設300症例の成績
大西洋,永田靖,平岡眞寛,白土博樹,五味光太郎,山下孝,有本卓朗,唐澤克之,新部譲,早川和重,高井良尋,木村智樹,武田篤也,大内敦,晴山雅人,小久保雅樹,原竜介,伊丹純,山田和成
臨床放射線2006; 51(10): 1145-53
乳房切除後放射線治療の有用性の検討
大渕徹,雨宮厚,武田篤也
乳癌の臨床 2006; 21(5): 443-449
Differences in pulmonary function before vs. 1 year after hypofractionated stereotactic radiotherapy for small peripheral lung tumors.
Ohashi T, Takeda A, Shigematsu N, Kunieda E, Ishizaka A, Fukada J, Deloar HM, Kawaguchi O, Takeda T, Takemasa K, Isobe K, Kubo A.
Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1003-8.
Pro-gastrin-releasing peptide as a factor predicting the incidence of brain metastasis in patients with small cell lung carcinoma with limited disease receiving prophylactic cranial irradiation.
Yonemori K, Sumi M, Fujimoto N, Ito Y, Imai A, Kagami Y, Ikeda H.
Cancer. 2005 Aug 15;104(4):811-6.
Possible misinterpretation of demarcated solid patterns of radiation fibrosis on CT scans as tumor recurrence in patients receiving hypofractionated stereotactic radiotherapy for lung cancer.
Takeda A, Kunieda E, Takeda T, Tanaka M, Sanuki N, Fujii H, Shigematsu N, Kubo A.
Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1057-65.
Successful pregnancy and normal delivery after whole craniospinal irradiation in two patients.
Naoyuki Shigematsu, H. Shinmoto, N Ito, Etsuo Kunieda, Atsuya Takeda, Toshio Ohashi,, Osamu Kawaguchi, T Kawata, H Ito, S Kuribayashi , Atsushi K.
Anticancer Res. 2005 Sep-Oct;25(5):3481-7.
Benefits of axillary radiotherapy unclear in women with early stage breast cancer undergoing conservative breast surgery without axillary dissection.
Sanuki-Fujimoto N.
Cancer Treat Rev. 2005 Oct;31(6):496-500.
Small lung tumors: long-scan-time CT for planning of hypofractionated stereotactic radiation therapy-initial findings
Atsuya Takeda, Etsuo Kunieda, Naoyuki Shigematsu, Deloar M. Hossain, Takatsugu Kawase, Toshio Ohashi, Jun-ichi Fukada, Osamu Kawaguchi, Minoru Uematsu, Toshiaki Takeda, Kazuhiko Takemasa, Takeshige Takahashi, Atsushi Kubo.
Radiology. 2005 Oct;237(1):295-300.
治療計画装置を用いた乳癌術後照射法について(1)
武田篤也,茂松直之
臨床放射線 2005; 50(13): 1822-4
新しい放射線治療の概要
武田篤也,深田淳一,茂松直之,国枝悦夫
臨床外科 第60巻6号 2005 695-702
脳転移の治療
国枝悦夫,武田篤也,久保敦司
臨床雑誌「内科」第95巻第1号2005 104-107
【教科書等】各論F/乳腺 臨床雑誌「内科」第95巻第1号2005 104-107
放射線治療グリーンマニュアル(金原出版株式会社,2005/03/20)

武田篤也,近藤誠
ウサギ肺に対する定位照射による有害事象の実験的検討
川瀬貴嗣,国枝悦夫,ホサイン・デロア,笠松智孝,川口修,武田篤也,沓木章二,中原理紀,藤井博史,久保敦司
日本医学放射線学会雑誌(0048-0428)
Evaluation of novel modified tangential irradiation technique for breast cancer patients using dose-volume histograms.
Takeda A, Shigematsu N, Ikeda T, Kawaguchi O, Kutsuki S, Ishibashi R, Kunieda E, Takeda T, Takemasa K, Ito H, Uno T, Jinno H, Kubo A.
Int J.Radiation Oncology Biol.Phys.2004.03; 58(4): 1280-1288
Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study.
Onishi H, Araki T, Shirato H, Nagata Y, Hiraoka M, Gomi K, Yamashita T, Niibe Y, Karasawa K, Hayakawa K, Takai Y, Kimura T, Hirokawa Y, Takeda A, Ouchi A, Hareyama M, Kokubo M, Hara R, Itami J, Yamada K.
Cancer. 2004 Oct 1;101(7):1623-31.
Treatment of breast carcinoma in patients with clinically negative axillary lymph nodes using radiotherapy versus axillary dissection.
Fujimoto N, Amemiya A, Kondo M, Takeda A, Shigematsu N.
Cancer. 2004 Nov 15;101(10):2155-63.
Measurement of beam-axis displacement from the isocenter during three-dimensional conformal radiosurgery with a micro-multileaf collimator.
Etsuo Kunieda, Osamu Kawaguchi, Hidetoshi Saitoh, Tatsuya Fujisaki, Atsuya Takeda, Takatsugu Kawase, Hossain M. Delor, Naoyuki Shigematsu, Atsushi Kubo
Radiotherapy and Oncology 2004; 70: 45-48
Radiation injury after hypofractionated stereotactic radiotherapy for peripheral small lung tumors: serial changes on CT.
Takeda T, Takeda A, Kunieda E, Ishizaka A, Takemasa K, Shimada K, Yamamoto S, Shigematsu N, Kawaguchi O, Fukada J, Ohashi T, Kuribayashi S, Kubo A.
AJR Am J Roentgenol. 2004 May;182(5):1123-8.
【教科書等】Ⅳ/治療の進歩 10/肺癌に対する定位放射線治療と放射線肺障害: 273-278 呼吸器2004(中外医学社,2004/01/30)
武田篤也,竹田利明,石坂彰敏
結核腫に隣接して発生したため偶然見つかった肺腺癌の1例
竹政和彦,竹田利明,島田恭子,山本星河,武田篤也
日本医学放射線学会雑誌63巻4号 192
原発性および転移性肺腫瘍に対する定位放射線治療
国枝悦夫,川瀬貴嗣,武田篤也,笠松智孝,川口修,沓木章二,茂松直之,久保敦司
臨床放射線 2003.5; 48: 609-61
体幹部定位放射線治療
国枝悦夫,武田篤也,久保敦司
慶應医学 80(2): 33-36, 2003
上肢に発生した木村病の1例
竹政和彦,竹田利明,田中道雄,大須賀香絵,島田恭子,武田篤也,鈴木謙三
画像診断 2002.2; 22(3): 302-6
頭蓋骨に浸潤した肥厚性脳硬膜炎の1例
竹政和彦,竹田利明,武田篤也,島田恭子,大須賀香絵,鈴木謙三
臨床放射線 2002.4; 47(4): 548-551
神経線維腫症1型に合併した動脈破裂の2例
竹田利明,竹政和彦,武田篤也,大須賀香絵,島田恭子,鈴木謙三
臨床放射線 2002.6; 47(6): 810-5
Intra-arterial CT-angiography for cerebral arteriovenous malformation--initial experiences for treatment planning of radiosurgery.
Kunieda E, Kawaguchi O, Onozuka S, Momoshima S, Takeda A, Shigematsu N, Hashimoto S, Ohira T, Kubo A.
Int J Radiat Oncol Biol Phys. 2002 Nov 15;54(4):1121-33.
A new bisphosphonate treatment option for giant cell tumors.
Fujimoto N, Nakagawa K, Seichi A, Terahara A, Tago M, Aoki Y, Hosoi Y, Ohtomo K.
Oncol Rep. 2001 May-Jun;8(3):643-7.
Breast-conserving therapy for ductal carcinoma in situ.
Takeda A, Shigematsu N, Kondo M, Amemiya A, Kawaguchi O, Kutsuki S, Ishibashi R, Kawata T, Masago K, Fukada J, Kubo A.
Oncol Rep. 2001; 8(4): 835-9
Cell killing and mutation induction by heavy ion beams.
Shigematsu N, Ihara N, Kawata T, Kawaguchi O, Takeda A, Ishibashi R, Kutsuki S, Kubo A, Kanai T, Furusawa Y, Isobe K, Uno T, Ito H.
Int J Mol Med. 2001; 7(5): 509-13 May
Severe COPD is correlated with mild radiation pneumonitis following stereotactic body radiotherapy.
Takeda A, Kunieda E, Ohashi T, Aoki Y, Oku Y, Enomoto T, Nomura K, Sugiura M.
Chest. 2011 Sep 1.
マイクロマルチリーフコリメータ(MMLC)によるラジオサージャリー
国枝悦夫,川口修,大平貴之,小野塚聡,茂松直之,深田淳一,武田篤也,川瀬貴嗣,久保敦司
定位放射線治療 7: 25-31, 2001
硬化性肝癌の1例
竹田利明,竹政和彦,大須賀香絵,武田篤也,谷口潤,香宗我部慈,鈴木謙三
日独医報46巻3-4 344
胃軸捻転を伴い,緊急手術を要した小児のBochdalek herniaの一例
竹政和彦,小林 剛,竹田利明,田村良子,武田篤也
臨床放射線 2000.3; 45: 428-432
自然退縮を示した肝細胞癌の2症例
竹政和彦,小林剛,竹田利明,田村良子,武田篤也
臨床放射線 2000.3; 45: 433-436
子宮の脂肪性腫瘍の一例
竹政和彦,小林剛,竹田利明,田村良子,武田篤也,鈴木謙三
臨床放射線 2000.10; 45: 1207-1210
肺限局型の非定型的Wegener's granulomatosisの一例
竹政和彦,小林剛,竹田利明,田村良子,武田篤也
臨床放射線 2000.2; 45: 329-332
巨大な房を持つ腎solitary multilocular cystの1例
田村良子,小林剛,竹田利明,竹政和彦,武田篤也,鈴木謙三
臨床放射線2000; 45(8): 987-991
A case of aortoduodenal fistula occurring after surgery and radiation for pancreatic cancer.
Masaki Kitajima, Thakahashi Shin, Ueda Masakazu, Hoshimoto Sojun, Jun Koizumi, Matsumoto Kenji, Hidekazu Suzuki, Atsuya Takeda, Syoji Kutsuki, Hajime Okita, Jun-ichi Hata.
Keio J Med 2000; 49(1): 35-44
乳房温存療法 適応の拡大
武田篤也,近藤誠,雨宮厚
臨床放射線2000; 45(11): 1367-1374 10月臨時増刊号
Modified tangential irradiation technique for breast cancer: how to cover the entire axillary region.
Atsuya Takeda, Naoyuki Shigematsu, Makoto Kondo, Atsushi Amemiya, Osamu Kawaguchi, Michinao Sato, Shoji Kutsuki, Kazuhito Toya, Ryochi Ishibashi, Takatsugu Kawase, Nobuhiro Tsukamoto, Atsushi Kubo.
Int J.Radiation Oncology Biol.Phys.2000; 46(4): 815-22
Indications of stereotactic irradiation for brain lesions
Naoyuki Shigematsu, Etsuo Kunieda, Osamu Kawaguchi, Atsuya Takeda, Noriko Ihara, Shoji Yamashita, Atsushi Kubo, Hisao Ito.
Acta Oncologica 2000; 39(5): 597-603
Late retinal Complications of Radiation Therapy for Nasal and Paranasal Malignancies.
Atsuya Takeda, Naoyuki Shigematsu, Saburosuke Suzuki,Masato Fujii, Tetsuya Kawata, Osamu Kawaguchi,Takashi Uno, Hideyuki Takano ,Atsushi Kubo, Hisao Ito.
Int J.Radiation Oncology Biol.Phys.1999; 44(3): 599-605
feasibiity of frameless stereotactic high-dose radiation therapy for primary or metastatic liver tumor.
Michinao Sato, Minoru Uematsu, Fuyumi Yamamoto, Akira Shioda, Kazuhiko Tahara, Toshiharu Fukui, Hisaaki Yokoyama, Atsuya Takeda, Jun Koizumi, Tatsumi Kaji, Shigeru Kosuda, Shoichi Kusano.
J.of Radiosurgery 1998; 1(3): 233
上咽頭癌の放射線治療-外照射-
武田篤也,茂松直之,藤井正人
JOHNS (Journal of Otolaryngology,Head and Neck Surgery) 1998;14(11):1565-8
肝細胞癌に対するTAEと組み合わせたstereotactic radiation therapy
山本富裕美,植松稔,武田篤也,他
Liver Cancer ; 3(2): 147-152
Prognostic factors of nasopharyngeal carcinoma treated by radiotherapy.
茂松直之,伊東久夫,沖陽輔,川田哲也,鈴木天之,武田篤也,植松稔,久保敦司,藤井正人,神崎仁
日本医学放射線学会雑誌1996; 56(14): 1050-5
膵癌 診断法の進歩と問題点 画像診断 CT,MRI
井筒睦,鈴木孝司,武田篤也,他
臨床科学; 31(3): 263-270

業績・研究